VCG
TMO icon

Vantage Consulting Group’s Thermo Fisher Scientific TMO Stock Holding History

Vantage Consulting Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-167
Closed -$78K – 1436
2020
Q4 		$78K Buy
+167
New +$78.3K 0.01% 262

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vantage Consulting Group's TMO Position: Q1 2021 in Review

Vantage Consulting Group sold out of Thermo Fisher Scientific (TMO) in Q1 2021, closing a stake of 167 shares — an estimated $78K sold.

Vantage Consulting Group first reported a position in TMO in Q4 2020 and held it in 1 quarter. The position peaked at $78K in Q4 2020. 2,041 funds tracked by Wall St. Rank hold TMO as of Q1 2021.

  • Vantage Consulting Group reported no remaining Thermo Fisher Scientific position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 167 Thermo Fisher Scientific shares in Q1 2021, an estimated $78K.
  • Vantage Consulting Group first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's Thermo Fisher Scientific position peaked at $78K in Q4 2020.
  • 2,041 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.